MEDTRONIC PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.23 USD | +0.12% |
|
-3.23% | -2.61% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Apr. 10 | Medtronic plc Announces New Advancements in Artificial Intelligence for Endoscopic Care by Unveiling ColonPRO | CI |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an enterprise value anticipated at 3.99 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -1.83% | 106B | C | ||
| +0.12% | 189B | C+ | ||
| -2.81% | 67.94B | A | ||
| +10.46% | 52.48B | B- | ||
| +14.72% | 46.63B | B- | ||
| -3.43% | 38.9B | B+ | ||
| +8.83% | 27.82B | A- | ||
| +4.13% | 26.97B | B | ||
| +6.56% | 25.94B | B | ||
| +3.99% | 25.58B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- MDT Stock
- Ratings Medtronic plc
